Featured NCORP Trials

MUSC Hollings Cancer Center and its affiliate network are part of the National Cancer Institute Community Oncology Research Program (NCORP). The goal of the NCORP program is to make cancer clinical trials more accessible by offering them in the communities where patients live. The NCORP program is part of Hollings' larger efforts to improve access to care across South Carolina.

There are a number of important NCORP trials studying ways to improve cancer care delivery, prevention, and symptom management. Details on a few of these featured NCORP trials are listed below.

If you or someone you know would like more information about how to participate, click on the study-specific links to submit your information. It will be reviewed by a member of our Hollings clinical trials team. For more information, you may also submit a contact form and someone will reach out to you.

S2417CD: A Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of an Intervention Called Current Together after Cancer (CTAC) to Promote Guideline-Concordant Colorectal Cancer Surveillance

Principal Investigator: Maggie Westfal, M.D.

This phase III trial evaluates whether a web-based intervention called Current Together after Cancer (CTAC) works to increase the number of patients with surgically removed (resected) colorectal cancer who receive surveillance care that aligns with current guidelines. Surveillance care after resection of colorectal cancer is critical to detect potentially curable return of disease (recurrence), yet up to 60% of colorectal cancer survivors fail to receive surveillance.

NRG-CC015: Harnessing E-mindfulness Approaches for Living After Breast Cancer - HEAL ABC

Principal Investigator: Dali Edwards, D.O.

The goal of this trial is to determine if a digital mindfulness meditation-based intervention program can improve the mental health and well-being among younger breast cancer survivors with elevated symptoms of depression. Mindfulness meditation programs provided in person have been shown to be helpful for younger breast cancer survivors. This study will compare different digital approaches for mindfulness training to see which is the most effective.

WF2304/A172401: Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics

Principal Investigator: Erin McClure, Ph.D.

This study examines the association between cannabis and/or cannabinoid use and cancer-related symptoms assessed monthly for one year in adults newly diagnosed with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer who are planning or recently started to receive one or more systemic cancer directed therapies with chemotherapy and/or immune check point inhibitors (ICIs).